Publications by authors named "Albert Assad"

Claim this Profile
T
Treatment comparison of hydroxyurea versus ruxolitinib in essential thrombocythaemia: A matched-cohort analysis.
Michael R Grunwald, Ellen K Ritchie, Elisa Rumi, Albert Assad, J E Hamer-Maansson

EJHaem· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 study of add-on parsaclisib for patients with myelofibrosis and suboptimal response to ruxolitinib: final results.
Abdulraheem Yacoub, Uma Borate, Raajit K Rampal, Haris Ali, Eunice S Wang, Albert Assad

Blood Adv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the PI3K pathway in myeloproliferative neoplasms.
Aaron T Gerds, Niccolo Bartalucci, Albert Assad, Abdulraheem Yacoub

Expert Rev Anticancer Ther· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Acceleration of spleen segmentation with end-to-end deep learning method and automated pipeline" [Comput. Biol. Med. 107 (2019) 109-117].
Hyeonsoo Moon, Yuankai Huo, Richard G Abramson, Richard Alan Peters, Albert Assad

Comput Biol Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Splenomegaly Segmentation on Multi-Modal MRI Using Deep Convolutional Networks.
Yuankai Huo, Zhoubing Xu, Shunxing Bao, Camilo Bermudez, Hyeonsoo Moon, Albert Assad

IEEE Trans Med Imaging· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acceleration of spleen segmentation with end-to-end deep learning method and automated pipeline.
Hyeonsoo Moon, Yuankai Huo, Richard G Abramson, Richard Alan Peters, Albert Assad

Comput Biol Med· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Splenomegaly Segmentation by Learning from Heterogeneous Multi-Source Labels.
Yucheng Tang, Yuankai Huo, Yunxi Xiong, Hyeonsoo Moon, Albert Assad

Proc SPIE Int Soc Opt Eng· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase Ib/II Study of the JAK1 Inhibitor, Itacitinib, plus -Paclitaxel and Gemcitabine in Advanced Solid Tumors.
Gregory L Beatty, Safi Shahda, Thaddeus Beck, Nikhil Uppal, Steven J Cohen, Albert Assad

Oncologist· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, double-blind, phase two study of ruxolitinib plus regorafenib in patients with relapsed/refractory metastatic colorectal cancer.
David Fogelman, Antonio Cubillo, Pilar García-Alfonso, María Luisa Limón Mirón, John Nemunaitis, Albert Assad

Cancer Med· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SynSeg-Net: Synthetic Segmentation Without Target Modality Ground Truth.
Yuankai Huo, Zhoubing Xu, Hyeonsoo Moon, Shunxing Bao, Albert Assad

IEEE Trans Med Imaging· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADVERSARIAL SYNTHESIS LEARNING ENABLES SEGMENTATION WITHOUT TARGET MODALITY GROUND TRUTH.
Yuankai Huo, Zhoubing Xu, Shunxing Bao, Albert Assad, Richard G Abramson

Proc IEEE Int Symp Biomed Imaging· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase Ib study of ruxolitinib + gemcitabine ± nab-paclitaxel in patients with advanced solid tumors.
Todd M Bauer, Manish R Patel, Andres Forero-Torres, Thomas J George, Albert Assad

Onco Targets Ther· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fully Convolutional Neural Networks Improve Abdominal Organ Segmentation.
Meg F Bobo, Shunxing Bao, Yuankai Huo, Yuang Yao, Jack Virostko, Albert Assad

Proc SPIE Int Soc Opt Eng· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Splenomegaly Segmentation using Global Convolutional Kernels and Conditional Generative Adversarial Networks.
Yuankai Huo, Zhoubing Xu, Shunxing Bao, Camilo Bermudez, Andrew J Plassard, Albert Assad

Proc SPIE Int Soc Opt Eng· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robust Multicontrast MRI Spleen Segmentation for Splenomegaly Using Multi-Atlas Segmentation.
Yuankai Huo, Jiaqi Liu, Zhoubing Xu, Robert L Harrigan, Albert Assad

IEEE Trans Biomed Eng· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ruxolitinib for essential thrombocythemia refractory to or intolerant of hydroxyurea: long-term phase 2 study results.
Srdan Verstovsek, Francesco Passamonti, Alessandro Rambaldi, Giovanni Barosi, Elisa Rumi, Albert Assad

Blood· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary analysis of a phase II open-label trial of INCB039110, a selective JAK1 inhibitor, in patients with myelofibrosis.
John O Mascarenhas, Moshe Talpaz, Vikas Gupta, Lynda M Foltz, Michael R Savona, Albert Assad

Haematologica· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-atlas Segmentation Enables Robust Multi-contrast MRI Spleen Segmentation for Splenomegaly.
Yuankai Huo, Jiaqi Liu, Zhoubing Xu, Robert L Harrigan, Albert Assad

Proc SPIE Int Soc Opt Eng· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-Atlas Spleen Segmentation on CT Using Adaptive Context Learning.
Jiaqi Liu, Yuankai Huo, Zhoubing Xu, Albert Assad, Richard G Abramson

Proc SPIE Int Soc Opt Eng· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in vivo characterization of MDX-1401 for therapy of malignant lymphoma.
Pina M Cardarelli, Maria-Cristina Moldovan-Loomis, Ben Preston, Amelia Black, David Passmore, Albert Assad

Clin Cancer Res· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II study of an anti-CD30 monoclonal antibody (MDX-060) in Hodgkin's lymphoma and anaplastic large-cell lymphoma.
Stephen M Ansell, Steven M Horwitz, Andreas Engert, Khuda Dad Khan, Thomas Lin, Albert Assad

J Clin Oncol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Santibanez-Gallerani A, Armstrong MB, Thaller SR. Improved esthetic results with fine-tip dermabond application technique. J CraniofacSurg. 2004 Sep; 15(5):890-2.
Albert Assad

J Craniofac Surg· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis